FOLD - Amicus Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

FOLD is currently covered by 10 analysts with an average price target of $14.73. This is a potential upside of $5.54 (60.28%) from yesterday's end of day stock price of $9.19.

Amicus Therapeutics's activity chart (see below) currently has 100 price targets and 93 ratings on display. The stock rating distribution of FOLD is 18.52% HOLD and 81.48% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 47.53% with an average time for these price targets to be met of 354.71 days.

Highest price target for FOLD is $21, Lowest price target is $12, average price target is $14.73.

Most recent stock forecast was given by KRISTEN KLUSKA from CANTOR FITZGERALD on 15-Jan-2025.

Currently out of the existing stock ratings of FOLD, 5 are a HOLD (18.52%), 22 are a BUY (81.48%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$21

$11.81 (128.51%)

$21

1 months 7 days ago
(15-Jan-2025)

0/7 (0%)

$11.73 (126.54%)

Buy

$12

$2.81 (30.58%)

$18

2 months 9 days ago
(13-Dec-2024)

0/4 (0%)

$2.64 (28.21%)

Buy

$17

$7.81 (84.98%)

$16

3 months 10 days ago
(12-Nov-2024)

6/15 (40%)

$6.51 (62.06%)

454

Buy

$15

$5.81 (63.22%)

$13

3 months 15 days ago
(07-Nov-2024)

2/4 (50%)

$4.02 (36.61%)

434

Buy

$15

$5.81 (63.22%)

$13

4 months 5 days ago
(17-Oct-2024)

2/9 (22.22%)

$3.03 (25.31%)

578

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is FOLD (Amicus Therapeutics) average time for price targets to be met?

On average it took 354.71 days on average for the stock forecasts to be realized with a an average price target met ratio 47.53

Which analyst has the current highest performing score on FOLD (Amicus Therapeutics) with a proven track record?

DEBJIT CHATTOPADHYAY

Which analyst has the most public recommendations on FOLD (Amicus Therapeutics)?

Debjit Chattopadhyay works at GUGGENHEIM and has 8 price targets and 4 ratings on FOLD

Which analyst is the currently most bullish on FOLD (Amicus Therapeutics)?

Michael Ulz with highest potential upside - $15.81

Which analyst is the currently most reserved on FOLD (Amicus Therapeutics)?

Gil Blum with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?